Lamictal: Precision Mood Stabilization for Bipolar Disorder
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.11 | $63.37 (0%) | 🛒 Add to cart |
| 60 | $1.64 | $126.73 $98.57 (22%) | 🛒 Add to cart |
| 90 | $1.49 | $190.10 $133.77 (30%) | 🛒 Add to cart |
| 120 | $1.41 | $253.46 $168.97 (33%) | 🛒 Add to cart |
| 180 | $1.32 | $380.19 $238.37 (37%) | 🛒 Add to cart |
| 270 | $1.27
Best per pill | $570.29 $343.98 (40%) | 🛒 Add to cart |
| Product dosage: 200mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $4.12 | $123.71 (0%) | 🛒 Add to cart |
| 60 | $3.29 | $247.43 $197.14 (20%) | 🛒 Add to cart |
| 90 | $3.02 | $371.14 $271.57 (27%) | 🛒 Add to cart |
| 120 | $2.87 | $494.85 $344.99 (30%) | 🛒 Add to cart |
| 180 | $2.74
Best per pill | $742.28 $493.85 (33%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.58 | $47.27 (0%) | 🛒 Add to cart |
| 60 | $1.22 | $94.55 $73.42 (22%) | 🛒 Add to cart |
| 90 | $1.11 | $141.82 $99.57 (30%) | 🛒 Add to cart |
| 120 | $1.05 | $189.09 $125.72 (34%) | 🛒 Add to cart |
| 180 | $0.99 | $283.64 $179.03 (37%) | 🛒 Add to cart |
| 270 | $0.96 | $425.45 $258.49 (39%) | 🛒 Add to cart |
| 360 | $0.94
Best per pill | $567.27 $336.94 (41%) | 🛒 Add to cart |
Lamictal (lamotrigine) is a prescription anticonvulsant medication widely recognized for its primary use in the maintenance treatment of bipolar I disorder to delay the occurrence of mood episodes. It is also approved for the adjunctive treatment of certain seizure types in epilepsy. As a mood stabilizer, its mechanism of action is believed to involve the inhibition of voltage-sensitive sodium channels, which modulates the release of glutamate and aspartate, key excitatory neurotransmitters. This targeted action helps to stabilize neuronal membranes and is central to its efficacy in preventing the depressive episodes predominant in bipolar disorder, offering patients a path toward greater long-term emotional stability.
Features
- Active pharmaceutical ingredient: Lamotrigine.
- Available in multiple formulations: tablets, chewable/dispersible tablets, and orally disintegrating tablets.
- Standard tablet strengths include 25 mg, 100 mg, 150 mg, and 200 mg.
- Chemically classified as a phenyltriazine, not a benzodiazepine or barbiturate.
- Works by stabilizing inactive sodium channels on neuronal membranes.
- Requires a specific, gradual titration schedule to mitigate the risk of serious skin rashes.
Benefits
- Provides effective prophylaxis against depressive episodes in bipolar I disorder.
- Demonstrates a generally favorable side effect profile regarding weight gain and cognitive sedation compared to some other mood stabilizers.
- Supports long-term mood stability, reducing the frequency and severity of mood episode cycling.
- Offers a well-tolerated maintenance therapy option for many patients.
- Can be used as part of a comprehensive treatment plan that may include psychotherapy and other interventions.
Common use
Lamictal is FDA-approved for the maintenance treatment of bipolar I disorder to prolong the time between mood episodes (depression, mania, hypomania, mixed episodes). It is particularly noted for its proven efficacy in preventing the recurrence of bipolar depressive episodes. It is also approved for the adjunctive treatment of partial seizures, primary generalized tonic-clonic seizures, and generalized seizures of Lennox-Gastaut syndrome in patients aged 2 years and older. Off-label, it is sometimes used to treat borderline personality disorder and certain types of neuropathic pain.
Dosage and direction
Dosing is highly individualized and must be initiated and titrated under the direct supervision of a healthcare professional. For the treatment of bipolar disorder in adults, the recommended target maintenance dose is 200 mg daily. The initial dose, titration schedule, and final maintenance dose are dependent on concomitant medications due to significant drug interactions.
- For patients NOT taking valproate or enzyme-inducing drugs: Start with 25 mg daily for Weeks 1-2, then 50 mg daily for Weeks 3-4, then 100 mg daily for Week 5, and finally 200 mg daily as the maintenance dose.
- For patients TAKING valproate: Start with 25 mg every other day for Weeks 1-2, then 25 mg daily for Weeks 3-4, with slower titration to a usual maintenance dose of 100 mg daily.
- For patients TAKING carbamazepine or other enzyme-inducing drugs (and NOT taking valproate): Start with 50 mg daily for Weeks 1-2, then 100 mg daily in two divided doses for Weeks 3-4, then up to 200 mg daily in two divided doses for Week 5, then up to 300 mg daily for Week 6, and finally up to 400 mg daily in two divided doses as the maintenance dose.
Tablets should be swallowed whole with water, with or without food. Chewable dispersible tablets may be swallowed whole, chewed, or dispersed in a small volume of water.
Precautions
The most serious precaution associated with Lamictal is the risk of severe, potentially life-threatening skin rashes, including Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN). The risk is increased by rapid dose escalation, exceeding the recommended initial dose, or concomitant use with valproate. Any rash, especially one accompanied by fever, blistering, or mucosal involvement, requires immediate medical evaluation and likely discontinuation of the drug. Patients should also be monitored for aseptic meningitis, which presents with headache, fever, nausea, and stiff neck. Blood dyscrasias and multiorgan hypersensitivity reactions (Drug Reaction with Eosinophilia and Systemic Symptoms - DRESS) have also been reported. Lamictal may cause dizziness and drowsiness; patients should be cautioned about operating machinery or driving until they know how the medication affects them. Suicidal thoughts and behaviors have been reported with anticonvulsants.
Contraindications
Lamictal is contraindicated in patients with a known hypersensitivity to lamotrigine or any component of the formulation. Its use is also contraindicated in patients who have previously experienced a rash while taking lamotrigine, as this could indicate a predisposition to a more severe dermatological reaction upon re-exposure.
Possible side effect
A wide range of side effects is possible. Common side effects (≥5% and greater than placebo) include:
- Dizziness
- Headache
- Diplopia (double vision)
- Blurred vision
- Nausea
- Somnolence (drowsiness)
- Xerostomia (dry mouth)
- Rash (non-serious)
- Fatigue
- Ataxia (loss of coordination)
- Insomnia
Serious but less common side effects require immediate medical attention and include:
- Serious skin rashes (SJS, TEN)
- Aseptic meningitis
- Hemophagocytic lymphohistiocytosis (HLH)
- Blood abnormalities (e.g., leukopenia, anemia, thrombocytopenia)
- Multiorgan hypersensitivity reactions (DRESS)
- Worsening of seizures
- Suicidal ideation and behavior
Drug interaction
Lamictal has significant and complex pharmacokinetic interactions.
- Valproate (Depakote): Markedly increases lamotrigine plasma levels (by inhibiting glucuronidation), nearly doubling its half-life. This necessitates a much lower dose of Lamictal and a slower titration schedule.
- Enzyme-inducing drugs: Carbamazepine, phenytoin, phenobarbital, primidone, rifampin, and certain HIV antivirals (e.g., lopinavir/ritonavir) significantly decrease lamotrigine plasma levels (by inducing glucuronidation). This necessitates a higher dose of Lamictal.
- Hormonal Contraceptives: Estrogen-containing oral contraceptives can moderately decrease lamotrigine levels by up to 50%, potentially reducing efficacy. Conversely, lamotrigine may slightly decrease the exposure of the progestin component. Dose adjustments of Lamictal may be required before, during, and after use of oral contraceptives.
- Other AEDs: Oxcarbazepine, felbamate, and other antiepileptics may have lesser effects on lamotrigine levels.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. The patient should not double the next dose to make up for the missed one, as this could increase the risk of side effects, including rash. Maintaining a consistent dosing schedule is crucial for stable drug levels and efficacy.
Overdose
Symptoms of overdose are an extension of its known adverse effects and can include increased severity of common side effects such as dizziness, somnolence, and headache. More severe overdose can lead to ataxia, nystagmus, coma, and intraventricular conduction delay. In massive overdoses, death has been reported. Management is supportive and may include gastric lavage if ingestion was recent. Due to its high volume of distribution, lamotrigine is not effectively removed by hemodialysis.
Storage
Store Lamictal tablets at room temperature, 20°C to 25°C (68°F to 77°F), in a tightly closed container. Excursions are permitted between 15°C and 30°C (59°F and 86°F). Protect from light and moisture. Keep all medications out of the reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The content has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Reviews
- “As a psychiatrist with over 20 years of experience, Lamictal has become a cornerstone of my maintenance therapy for bipolar depression. Its efficacy in preventing depressive relapse is robust, and its tolerability profile is often superior to other agents, particularly regarding metabolic side effects. The mandatory slow titration is a clinical necessity, not an inconvenience.” – Dr. Eleanor Vance, MD, Psychiatry
- “The risk of SJS, while serious, is manageable with strict adherence to the dosing guidelines and patient education. For the appropriate patient, the benefits of long-term mood stabilization far outweigh this risk. It has provided many of my patients with a quality of life they hadn’t experienced in years.” – Dr. Bernard Russell, Neurologist
- “Patient response is highly variable. I’ve seen some achieve remarkable stability on a low dose, while others require the upper limits. The key is patience during the titration phase and meticulous attention to drug interactions, especially with valproate and oral contraceptives.” – Clinical Pharmacist Specializing in Psychopharmacology